CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities
Net loss	$ (3,952,821)	$ (22,516,889)
Adjustments to reconcile net loss to cash used in operating activities:
Stock-based compensation expense	527,869	423,911
Depreciation and amortization	6,277,215	6,636,593
Bad debt expense	0	654,820
Rent paid by common stock	244,000	0
Gain on sale of assets	(9,631,712)	0
Deferred financing costs write off	1,390,727	0
Deferred federal income tax		5,306,000
Increase in fair value of derivative liability	(49,876)	(5,479,463)
Reduction in contingent consideration	0	(6,069,000)
Impairment of goodwill	0	4,922,353
Changes in operating assets and liabilities:
Accounts receivable	(4,636,805)	1,929,871
Inventory	(809,647)	9,072,305
Prepaid expenses	(1,250,496)	48,438
Costs in excess of billings	0	779,285
Accounts payable and accrued expenses	(1,893,370)	(8,539,803)
Deferred revenue	(323,891)	(139,319)
Other	(36,800)
Net cash used in operating activities	(14,145,607)	(12,970,898)
Cash flows from investing activities
Note receivable	0	2,495,180
Payments on capital leases	0	(172,654)
Proceeds from sale of assets	29,788,114	0
Costs related to sale of assets	(10,792,446)	0
Establish escrow account - restricted cash	(1,504,723)	0
Proceeds from the sale of assets	20,900	92,271
Acquisitions	0	(1,082,649)
Purchase of fixed assets	(1,628,859)	(1,811,653)
Net cash provided by (used in) investing activities	15,882,986	(479,505)
Cash flows from financing activities
Line of credit proceeds (payments), net	981,918	1,744,122
Proceeds from exercise of common stock options and warrants		11,306
Proceeds from sale of Series C Preferred Stock	4,000,000	0
Purchase/buy back/sale/conversion Series B and B-1 Preferred Stock	(11,189,849)	0
Proceeds from issuance of Series B Preferred stock	19,349,757	23,557,553
Issuance costs of Series B and B-1 Preferred Stock	(607,890)	0
Proceeds from notes payable	7,650,819	2,305,277
Payments made on notes payable	(20,986,063)	(19,419,567)
Net cash provided by (used in) financing activities	(801,308)	8,198,691
Net change in cash and cash equivalents	936,071	(5,251,712)
Cash and cash equivalents at beginning of the period	765,364	6,017,076
Cash and cash equivalents at end of period	1,701,435	765,364
SUPPLEMENTAL INFORMATION
Cash paid for interest during the year	1,688,628	3,563,145
Cash paid for income taxes during the year	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Common shares issued as payment	244,000	200,000
E-Source Holdings, LLC
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Fair value of warrants issued with Series B and B-1 Preferred Stock	2,867,264	0
Series A Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Preferred Stock into common stock	120	17
Series B Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Preferred Stock into common stock	5,104,881	100,795
Series B and Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Dividends-in-Kind accrued on Series B and B-1 Preferred Stock and retirement of a portion of the Series B Preferred Stock	9,822,196	779,310
Beneficial conversion feature	4,887,252	5,682,741
Accretion of discount on Series B and B-1 Preferred Stock	$ 1,762,378	$ 1,585,843